Proto Oncogene Drug Market By Product ( Axitinib, Ponatinib, Imatinib, Sunitinib, Pazopanib, Dabrafenib, Vandetanib, Vemurafenib, Cabozantinib ), By Application ( Clinics, Hospitals, Research Labs & Others ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 158

 ERC 9378


Proto Oncogene Drug Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

A proto-oncogene is a gene that has a tendency to become an oncogene as a result of mutations. Proto-oncogenes direct the proteins which support to regulate cell growth and differentiation. When the proto-oncogene attains an activating mutation, it becomes a tumor-generating agent in the form of oncogene. There are various types of proto-oncogenes such as RAS, WNT, MYC and many others. The tumor caused by this mutation, turns out in the form of Cancer. In the current scenario, cancer is considered to be a complex genetic disease. This is the reason, conventional anti-cancer, oncogene inhibition therapies are preferred in order to kill the tumor cells and restrain the sudden mutations. With the continuous advancement in technology, there are nearly 20 types of commercialized proto-oncogene inhibitor drugs available in the market. This is because Cancer, is rapidly spreading as a major disease, generating serious concerns all around the world. As per American Cancer Society, One out of every two men and one out of every three women have a tendency to generate cancer within them in their lifespan.

Proto-oncogene drug market is exhibiting a rapid growth at different levels as, pharmaceutical companies are strongly emphasizing on the provision of most efficient cancer drugs and in return, generating significant revenues through sales. The presence of a substantial cancer patient base and continuous development in drug therapy are the propelling agents for the growth of the very market. In addition to this, continuous initiatives taken by governments to increase awareness regarding cancer and its cure, coupled with the increasing R&D funds for the development of new formulations in order to decrease the side effects and increase the drug effectiveness will emerge out as the highly contributing factors for the growth of proto-oncogene drug market in the near future. However, the high cost of these drugs and lack of awareness among patients might act as a restraining factor for the growth of the very market.

The report provides detailed qualitative and quantitative analysis of the Global Proto Oncogene Drug Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely product and application in each of the major regions.

Global Proto Oncogene Drug Market Player Analysis -

The report presents detailed analysis of major players operating in Global Proto Oncogene Market. Few of them include. ARIAD Pharmaceuticals, AstraZeneca, Bayer Healthcare, Bristol-Myers Squibb, ChemGenex Pharmaceuticals, Dexa Medica, Eisai Pharmaceuticals, Exelixis, GlaxoSmithKline, Novartis, Onyx Pharmaceuticals, Pfizer and Plexxikon. A detailed coverage on these market players with information on their revenue from proto oncogene business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global Proto Oncogene drug market is segmented on the basis of product, application and geography. By product, the market is segmented into Axitinib (Inlyta), Ponatinib (Iclusig), Imatinib (Gleevec), Sunitinib (Sutent), Pazopanib (Votrient), Dabrafenib (Tafinlar), Vandetanib (Caprelsa), Vemurafenib (Zelboraf), Cabozantinib (Cabometyx & Cometriq), Sorafenib (Nexavar). On the basis of application, the market is categorized as Clinics, Hospitals and Others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Proto Oncogene Drug Market Segmentation

By Product
   • Axitinib (Inlyta)
   • Ponatinib (Iclusig)
   • Imatinib (Gleevec)
   • Sunitinib (Sutent)
   • Pazopanib (Votrient)
   • Dabrafenib (Tafinlar)
   • Vandetanib (Caprelsa)
   • Vemurafenib (Zelboraf)
   • Cabozantinib (Cabometyx & Cometriq)
   • Sorafenib (Nexavar)

By Application
   • Clinics
   • Hospitals
   • Research Labs & Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K.
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Proto Oncogene Drug Market Key Players

• ARIAD Pharmaceuticals
• AstraZeneca
• Bayer Healthcare
• Bristol-Myers Squibb
• ChemGenex Pharmaceuticals
• Dexa Medica
• Eisai Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Novartis
• Onyx Pharmaceuticals
• Pfizer
• Plexxikon

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Proto Oncogene Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Proto Oncogene Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!